241 related articles for article (PubMed ID: 1565306)
21. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.
Berenson AB; Wiemann CM; Rickerr VI; McCombs SL
Am J Obstet Gynecol; 1997 Mar; 176(3):586-92. PubMed ID: 9077611
[TBL] [Abstract][Full Text] [Related]
22. Hormonal treatment for bleeding irregularities in Norplant implant users.
Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
[TBL] [Abstract][Full Text] [Related]
23. Preliminary experience with Norplant in an inner city population.
Cullins VE; Blumenthal PD; Remsburg RE; Huggins GR
Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
[TBL] [Abstract][Full Text] [Related]
24. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
[TBL] [Abstract][Full Text] [Related]
25. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
26. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
27. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
[TBL] [Abstract][Full Text] [Related]
28. Use of Norplant implants in a New York City clinic population.
Gerber S; Westhoff C; Lopez M; Gordon L
Contraception; 1994 Jun; 49(6):557-64. PubMed ID: 8070260
[TBL] [Abstract][Full Text] [Related]
29. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
30. Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users.
Pasquale SA; Knuppel RA; Owens AG; Bachmann GA
Contraception; 1994 Aug; 50(2):109-16. PubMed ID: 7956210
[TBL] [Abstract][Full Text] [Related]
31. Injectable and implantable contraceptives.
Cullins VE
Curr Opin Obstet Gynecol; 1992 Aug; 4(4):536-43. PubMed ID: 1387011
[TBL] [Abstract][Full Text] [Related]
32. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
[TBL] [Abstract][Full Text] [Related]
33. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
[TBL] [Abstract][Full Text] [Related]
34. IMAP statement on Norplant subdermal contraceptive implant system.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1993 Apr; 27(2):1-3. PubMed ID: 12345306
[TBL] [Abstract][Full Text] [Related]
35. Menstrual bleeding patterns in Norplant-2 implant users.
Biswas A; Leong WP; Ratnam SS; Viegas OA
Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
[TBL] [Abstract][Full Text] [Related]
36. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
Fleming D; Davie J; Glasier A
Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
Au CL; Affandi B; Rogers PA
Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
[TBL] [Abstract][Full Text] [Related]
38. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
Goodger AM; Rogers PA; Affandi B
Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
[TBL] [Abstract][Full Text] [Related]
39. Experience of Thai women in Bangkok with Norplant-2 implants.
Chompootaweep S; Kochagarn E; Tang-Usaha J; Theppitaksak B; Dusitsin N
Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
[TBL] [Abstract][Full Text] [Related]
40. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C
Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
